Ozempic® is now indicated to reduce the risk of kidney disease worsening, kidney failure, and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease The approval is based on the results of the pivotal FLOW phase 3b kidney outcomes trial and addresses a…
